drugset / Trial / NCT04441073

Lignocaine Nebulization for Attenuation of Intubation Stress Response

NCT04441073 ↗

Phase 4 Unknown 100 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To study the effect of lignocaine nebulization on attenuation of the pressor response during induction and emergence of anesthesia in patients with severe pre-eclampsia

Timeline

Start
2021-02-24
Primary completion
2022-02-23
Completion
2022-02-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified — Other

Indications

No indication recorded.